-
1تقرير
المصدر: An Evaluation of Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00006016Test
-
2تقرير
المصدر: A Phase II Trial Of The Epothilone B Analog BMS-247550 (NSC 710428D) In Patients With Hepatobiliary Cancer
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00023946Test
-
3تقريرVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
المصدر: Phase I Study of a Recombinant Fowl Pox Vaccine rF-CEA (6D)/TRICOM Alone or With GM-CSF in Patients With Advanced CEA Expressing Adenocarinomas
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00028496Test
-
4تقرير
المصدر: Phase I Study of OSI-774 (NSC 718781) for Solid Tumors in Patients With Hepatic or Renal Dysfunction
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00030498Test
-
5تقرير
المصدر: A Phase II Trial of OSI-774 in Patients With Hepatocellular or Biliary Carcinoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00033462Test
-
6تقرير
المصدر: A Phase 2 Open-Label Study Of OSI-774 (NSC 718781) In Unresectable Hepatocellular Carcinoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00047333Test
-
7تقرير
المصدر: A Dose-Finding, Safety, And Pharmacokinetic Study Of The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor OSI-774 (NSC 718781) In Patients With Unresectable Hepatocellular Carcinoma And Moderate Hepatic Dysfunction
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00047346Test
-
8تقرير
المصدر: Siegel AB, Cohen EI, Ocean A, Lehrer D, Goldenberg A, Knox JJ, Chen H, Clark-Garvey S, Weinberg A, Mandeli J, Christos P, Mazumdar M, Popa E, Brown RS Jr, Rafii S, Schwartz JD. Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol. 2008 Jun 20;26(18):2992-8. doi: 10.1200/JCO.2007.15.9947.
Bevacizumab (RhuMAB-VEGF) In Hepatocellular Cancer For Patients With Unresectable Tumor (Without Invasion Of The Main Portal Vein Or Metastatic Disease) A Phase II Studyالوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00055692Test
-
9تقرير
المصدر: A Phase II Study of Oxaliplatin in Hepatocellular Cancer
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00052364Test
-
10تقرير
المصدر: A Phase II Study of ZD1839 (Iressa, Gefitinib, NSC 715055) in Advanced Unresectable Hepatocellular Carcinoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00071994Test
